COPD: The Inability to Fully ExhaleBy CherineAugust 17, 20220 People with COPD are not able to fully exhale what they have inhaled. Learn more about COPD with Dr Elizabeth Yu, pulmonologist @UCSF.
Tepotinib (Tepmetko) for METex14-altered NSCLCBy KayeJuly 27, 20220 Tepotinib (Tepmetko) was recently approved for the use of Non-Small Cell Lung Cancer (NSCLC). Find out about the Phase II VISION trial here.
Biologics For Severe Asthma: A Review of Dupilumab (Dupixent)By KayeJune 2, 20220 Asthma is one of the most common chronic respiratory conditions treated in the primary care setting in Singapore. Critically, it…
Chronic Obstructive Pulmonary Disease (COPD): Diagnosis, TreatmentBy Sunitha SFebruary 22, 20220 What is COPD? Chronic Obstructive Pulmonary Disease (COPD) is the progressive decline of lung function due to emphysema and/or chronic…
Bronchiectasis: All You Need To Know About ItBy Sunitha SFebruary 18, 20220 Bronchiectasis is a serious condition affecting the lungs. This condition mainly affects people above 75 years old, though it is…
COPD: Everything You Need To Know About ItBy Sunitha SNovember 18, 20210 According to the World Health Organisation (WHO), COPD, short for Chronic Obstructive Pulmonary Disease, is the third major cause of…
Advancements in COPD Management: Singapore’s HSA Approves Revefenacin (Yupelri®)By KayeNovember 16, 20210 Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterised by irreversible airflow limitation and associated with significant…
Pneumonia: Why Is It Dangerous?By Vicky LaiNovember 11, 20210 Pneumonia is the leading cause of death caused by infectious diseases in the world and accounts for 15% of deaths…
Allergies: How Do You Recognise Them?By Vicky LaiOctober 22, 20210 Allergies affect up to 20 percent of the world’s population. The severity of allergies varies amongst individuals and can range…
Casirivimab and Imdevimab: An Overview of its use in COVID-19 treatmentBy EmmaOctober 5, 20210 Hot on the heels of sotrovimab, the Health Science’s Authority (HSA) has granted pandemic special access route (PSAR) interim authorization…
